ZFX Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P17010 |
---|---|
Clone Names | 100324199 |
Gene ID | 7543 |
---|---|
Other Names | Zinc finger X-chromosomal protein, ZFX |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13564c was selected from the Center region of ZFX. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ZFX |
---|---|
Function | Probable transcriptional activator. |
Cellular Location | Nucleus. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene on the X chromosome is structurally similar to arelated gene on the Y chromosome. It encodes a member of thekrueppel C2H2-type zinc-finger protein family. The full-lengthprotein contains an acidic transcriptional activation domain (AD),a nuclear localization sequence (NLS) and a DNA binding domain(DBD) consisting of 13 C2H2-type zinc fingers. Studies in mouseembryonic and adult hematopoietic stem cells showed that this genewas required as a transcriptional regulator for self-renewal ofboth stem cell types, but it was dispensable for growth anddifferentiation of their progeny. Multiple alternatively splicedtranscript variants encoding different isoforms have beenidentified, but the full-length nature of some variants has notbeen determined.
References
Beausoleil, S.A., et al. Proc. Natl. Acad. Sci. U.S.A. 101(33):12130-12135(2004)Poloumienko, A. Genome 47(1):74-83(2004)Agate, R.J., et al. Mol. Biol. Evol. 21(2):384-396(2004)Murphy, W.J., et al. Nature 409(6820):614-618(2001)Taylor, D.M., et al. Mol. Reprod. Dev. 48(4):442-448(1997)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.